RNS System LGS Feasibility Study

Clinical trial NCT05339126 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05339126
Sponsor: NeuroPace
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Epilepsy Lennox Gastaut Syndrome Lennox-Gastaut Syndrome, Intractable Seizures Seizures, Generalized

Start date: 2022-10-04
Primary completion: 2026-05-31
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.